| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 03/26/2009 | WO2009038784A1 Triazole fused heteroaryl compounds as p38 kinase inhibitors |
| 03/26/2009 | WO2009037308A1 Inhibitors of the interaction between mdm2 and p53 |
| 03/26/2009 | WO2009036996A2 Small molecule bradykinin b1 receptor antagonists |
| 03/26/2009 | WO2009036955A1 Naphtyl-substituted sulfonamides |
| 03/26/2009 | WO2009036590A1 Compounds isolated from antrodia cinnamomea and use thereof |
| 03/26/2009 | WO2009006389A8 Pyrimidine derivatives useful as raf kinase inhibitors |
| 03/26/2009 | WO2008145688A3 Pyrrolopyridine compounds, process for their preparation, and their use as medicaments |
| 03/26/2009 | WO2008097824A3 Use of arsenic compounds for treatment of pain and inflammation |
| 03/26/2009 | US20090082567 2,4-pyrimidinediamine compounds and their uses |
| 03/26/2009 | US20090082463 N-substituted phenylacetamide derivative and pharmaceutical composition containing the same |
| 03/26/2009 | US20090082435 Methods, Compositions, And Compounds For Modulation Of Monoacylglycerol Lipase, Pain, And Stress-Related Disorders |
| 03/26/2009 | US20090082426 Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof |
| 03/26/2009 | US20090082417 Deuterium-enriched sdx-101 |
| 03/26/2009 | US20090082400 Soluble pyrone analogs methods and compositions |
| 03/26/2009 | US20090082393 New addition salts of angiotensin-converting enzyme inhibitors with no donor acids, a process for their preparation and pharmaceutical compositions containing them |
| 03/26/2009 | US20090082383 Deuterium-enriched buprenorphine |
| 03/26/2009 | US20090082377 Matrix Metalloproteinase Inhibitors |
| 03/26/2009 | US20090082369 Pyrrolo[2,3d]pyrimidine compositions and their use |
| 03/26/2009 | US20090082368 Methods of modulating neurotrophin-mediated activity |
| 03/26/2009 | US20090082362 Use of capsaicin receptor antagonists to treat symptoms of tear gas exposure |
| 03/26/2009 | US20090082360 Use of tyrosine kinase inhibitors for treating CNS disorders |
| 03/26/2009 | US20090082358 Vanilloid receptor ligands and their use in treatments |
| 03/26/2009 | US20090082356 Pyrazine Derivatives and Use as P13k Inhibitors |
| 03/26/2009 | US20090082349 Thiazolones for use as pi3 kinase inhibitors |
| 03/26/2009 | US20090082345 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors |
| 03/26/2009 | US20090082330 Certain substituted amides, method of making, and method of use thereof |
| 03/26/2009 | US20090082314 Targeting Prodrugs for the Treatment of Gastrointestinal Diseases |
| 03/26/2009 | US20090082307 Culturing Lac Z-Y+ E. coli cell on glycerol and glucose in presence of lactose as exogenous precursor and isopropyl beta -D-thiogalactoside as inducer under conditions inducing the internalization according to a mechanism of active transport of exogenous precursor by cell and production of lactose |
| 03/26/2009 | US20090082292 inhibiting angiogenesis; corneal graft rejection; age related macular degeneration; diabetic retinopathy; dermatological disease |
| 03/26/2009 | US20090082267 Prevention and Reduction of Blood Loss |
| 03/26/2009 | US20090081732 Antibodies to human il-1beta |
| 03/26/2009 | US20090081729 Compositions and Methods Comprising a Ligand of ChemerinR |
| 03/26/2009 | US20090081309 Stabilized Oral Suspension Formulation |
| 03/26/2009 | US20090081290 Tamper resistant dosage forms |
| 03/26/2009 | US20090081256 Transgenic plant-based vaccines |
| 03/26/2009 | US20090081242 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 03/26/2009 | US20090081208 Optimized Fc variants and methods for their generation |
| 03/26/2009 | US20090081185 Apoptotic agents |
| 03/26/2009 | US20090081162 Method for downregulating an immune reaction |
| 03/26/2009 | US20090081123 Pharmaceutical compounds |
| 03/26/2009 | CA2703019A1 Method and compositions for treatment or prevention of inflammatory conditions |
| 03/26/2009 | CA2700051A1 Small molecule bradykinin b1 receptor antagonists |
| 03/26/2009 | CA2699888A1 Combretum laurifolium mart. extract and methods of extracting and using such extract |
| 03/26/2009 | CA2699849A1 Inhibitors of the interaction between mdm2 and p53 |
| 03/25/2009 | EP2039779A1 Screening method |
| 03/25/2009 | EP2039700A2 Novel anti-inflammatory androstane derivatives |
| 03/25/2009 | EP2039681A1 Cycloalkene derivatives, process for production of the derivatives, and use of the same |
| 03/25/2009 | EP2039361A2 Use of immunomodulatory compounds |
| 03/25/2009 | EP2039358A1 Pharmaceutical compositions comprising a macrolide and an acid |
| 03/25/2009 | EP2038289A2 Thieno-[2,3-d]pyrimidine and thieno-pyridazine compounds and methods of use |
| 03/25/2009 | EP2038287A1 Spiro[benzopyran]or spiro[benzofuran]derivatives which inhibit the sigma receptor |
| 03/25/2009 | EP2038279A2 Substituted pyrazolo [1,5- alpha] pyridine compounds and their methods of use |
| 03/25/2009 | EP2038266A2 Compounds as cannabinoid receptor ligands and uses thereof |
| 03/25/2009 | EP2038251A1 Positively charged water-soluble prodrugs of aspirin |
| 03/25/2009 | EP2037956A2 Simultaneous, separate or sequential therapeutic use of at least one botulinum neurotoxin and of at least one opiate derivative |
| 03/25/2009 | EP2037902A1 Cannabinoids for use in the treatment of neuropathic pain |
| 03/25/2009 | EP2037741A1 Compositions and methods relating to novel compounds and targets thereof |
| 03/25/2009 | EP2000469A9 Acylaminopiperidine compound |
| 03/25/2009 | EP1432684B1 Pyridinic sulfonamide derivatives, method of production and use thereof |
| 03/25/2009 | EP1407777B1 Hydrangea(e) for the prevention or treatment of arthritis |
| 03/25/2009 | EP1377579B1 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| 03/25/2009 | EP1299421B1 Antibodies to human mcp-1 |
| 03/25/2009 | EP1287035B1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 03/25/2009 | CN101395158A Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors |
| 03/25/2009 | CN101395141A Imidazole-based compounds, compositions comprising them and methods of their use |
| 03/25/2009 | CN101391086A Oral medicine capable of expelling pathogenic cold from channel and relieving pain |
| 03/25/2009 | CN101391082A Plaster for promoting blood circulation and easing pain |
| 03/25/2009 | CN101391068A External analgesic traditional Chinese medicine |
| 03/25/2009 | CN101391051A Traditional Chinese medicine composition for treating periarthritis humeroscapularis using external application |
| 03/25/2009 | CN101391050A Traditional Chinese medicine capsule for treating cervical-shoulder disease |
| 03/25/2009 | CN101391046A Antalgic traditional Chinese medicine compound preparation and preparation method thereof |
| 03/25/2009 | CN101391005A Health-care medicinal wine capable of relaxing muscles and joints and promoting blood circulation |
| 03/25/2009 | CN101390961A Medicine composition of aconitum pendulum non-alkaloids active site and preparation method thereof |
| 03/25/2009 | CN101390957A Ancestral traditional Chinese medicine composition for treating injuries from falls |
| 03/25/2009 | CN101390954A External traditional Chinese medicine wine for treating scapulohumeral periarthritis |
| 03/25/2009 | CN101390942A Traditional Chinese medicine pills for treating bone-pain arthralgia |
| 03/25/2009 | CN101390883A Dried wood-louse extract, preparation method and use thereof in preparing analgesic |
| 03/25/2009 | CN101390881A Preparation of wood louse powder extract and uses thereof |
| 03/25/2009 | CN101390869A Use of high-purity forsythin in preparing bacteriostasis, antivirus and other medicine |
| 03/25/2009 | CN101390845A Hard capsule containing etodolac |
| 03/25/2009 | CN101390844A Arginine ibuprofen tablet and preparation method thereof |
| 03/25/2009 | CN100471873C A series of polypeptide capable of blocking IL-6 |
| 03/25/2009 | CN100471869C Preparation and assaying of peptide dextran possessing detectable oral absorption immune regulation of coriolus versicolor |
| 03/25/2009 | CN100471853C Phenyl-thiophene type vitamin D receptor modulators |
| 03/25/2009 | CN100471838C VLA-4 inhibitors |
| 03/25/2009 | CN100471512C Medicinal wine for treating rheumatism and rheumatoid disease and its prepn. method |
| 03/25/2009 | CN100471489C Soft capsule containing Lamiophlomis rotata Kudo. root extract |
| 03/24/2009 | US7507839 e,g, 1,5-bis(5-acetyl-4,7-dimethoxybenzofuran-6-yloxy)pentane;potassium channel modulator; antiinflammatory agent, autoimmune diseases; immunosuppressant; multiple sclerosis, rejection of foreign organ transplants |
| 03/24/2009 | US7507816 Compounds for treatment of inflammation, antidepressants, nervous system disorders, cardiovascular disorders or analgesics from mannich reaction |
| 03/24/2009 | US7507795 Zcytor17 ligand cytokine; immunostimulators system, and proliferation and/or development of hematopoietic cells in vitro and in vivo; transcription, gene expression, culturing; anticarcinogenic and antiinflammatory agents; diabetes, pancreatitis, inflammatory bowel disease; autoimmune diseases |
| 03/24/2009 | US7507787 Polynucleotides; induce immunology response; antiinflammatory agents; detection polynucleotide patten |
| 03/24/2009 | US7507767 Sulfonamide-containing benzene derivatives which exhibit anti-inflammatory and immunodulatory activity |
| 03/24/2009 | US7507762 Substituted 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/24/2009 | US7507759 Methods of using(+)-2-[1-(3-ethoxy-4methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3,-dione |
| 03/24/2009 | US7507753 Biaryl compound and use thereof |
| 03/24/2009 | US7507717 Inhibitors of neuronal amine transporters of neurotransmitters, such as noradrenaline, serotonin, dopamine, glutamic acid and glycine; pain, inflammation, incontinence, cardiovascular conditions and mood disorders |
| 03/24/2009 | US7507706 Administering a polypeptide to reduce airway hyper responsiveness or reduce the increase of mucus-containing cells in the airway epithelium; IL-13 binding chains of the interleukin-13 receptor |
| 03/24/2009 | US7507542 Autoimmune diseases; inflammatory bowel disease; multiple sclerosis; rheumatic diseases; modulate gene expression |
| 03/24/2009 | US7507414 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 03/24/2009 | US7507398 Using condensation aerosol (MMAD of less than 5 microns) formed by vaporizing a thin layer of the drug on a solid support and condensing the vapor to treat anxiety, vertigo, alcohol or nicotine withdrawal, sedation, hot flashes, peptic ulcers or for hormone replacement therapy, or pregnancy prevention |